• WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership prnasia
    May 27, 2021
    WuXi Biologics, a global company with leading open-access biologics technology platforms, and OncoC4, Inc., a privately-held, clinical-stage biopharmaceutical company, today announced that the companies have entered into an exclusive contract ...
PharmaSources Customer Service